Suit Against Isolagen, Underwriters Moves Forward
A proposed class action lawsuit alleging securities fraud on the part of biotechnology company Isolagen Inc. and 11 current and former directors will move forward with all claims intact, a judge...To view the full article, register now.
Already a subscriber? Click here to view full article